The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / How Leukemia Develops Over Decades
Hematology Genetics and epigenetics Omics Screening and monitoring Research and Innovations Molecular Pathology

How Leukemia Develops Over Decades

Long-term tracking of blood mutations reveals how acute myeloid leukemia develops and identifies potential opportunities for earlier risk assessment

11/17/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

To track how AML-associated mutations and mutated blood-cell populations change before diagnosis, and assess whether these patterns distinguish people who later develop AML.

Approach:
  • Longitudinal samples: Researchers analyzed annual blood samples from 47 women who later developed AML and 46 age-matched controls who remained free of blood cancer.
  • Mutation tracking: Using TETRIS-seq, the team tracked AML-associated mutations and changes in the size of blood-cell populations carrying them.
  • Risk analysis: The researchers also analyzed UK Biobank data to assess whether extensive expansion of mutated cell populations was associated with myeloid leukemia.
Key Findings:
  • In about two-thirds of participants who developed AML, the first cancer-associated mutation was estimated to have appeared before age 20.
  • Mutated cell populations initially grew slowly; their growth accelerated as additional mutations accumulated, sometimes decades before clinical diagnosis.
  • Age-related mutations occurred in both groups, but future AML cases showed more extensive expansion and competition among mutated cell populations.
  • UK Biobank analysis found substantially increased odds of myeloid leukemia among individuals with evidence of extensive expansion of a mutated cell population.
Interpretation:

The findings suggest that assessing the extent of mutated-cell expansion, in addition to identifying mutations, may improve molecular risk assessment. The study does not establish a screening test.

Limitations:
  • The cohort was relatively small and consisted of older women.
  • About one-fifth of AML cases showed little detectable warning before diagnosis.
  • Further validation is needed to determine whether monitoring these changes can reliably identify high-risk individuals or guide preventive intervention.
Conclusion:

The study describes AML-associated genetic changes that can begin decades before diagnosis, while noting that the findings require further validation.

Sources:
  • Article context; research published in Nature

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.